Vical Incorporated Stock Nasdaq

Stocks

28/01/25	Fresh Tracks Therapeutics Announces Special Distribution	CI
16/03/24	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
21/12/23	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index	CI
18/12/23	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from NASDAQ Composite Index	CI
14/11/23	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
20/09/23	Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	MT
20/09/23	US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	MT
20/09/23	Top Premarket Gainers	MT
20/09/23	Fresh Tracks Therapeutics' Board Approves Liquidation Plan; Shares Rise After Hours	MT
20/09/23	Fresh Tracks Therapeutics, Inc. Announces Chief Executive Officer Changes	CI
20/09/23	Fresh Tracks Therapeutics, Inc. Announces Executive Changes	CI
12/08/23	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
26/07/23	Fresh Tracks Therapeutics, Inc. Announces Resignation of Robert B. Brown from the Board of Directors, Effective Immediately	CI

15/11/22	Oppenheimer Adjusts Fresh Tracks Therapeutics Price Target to $4 From $9, Maintains Outperform Rating	MT
27/09/22	Oppenheimer Adjusts Price Target on Fresh Tracks Therapeutics to $9 From $1, Maintains Outperform Rating	MT
16/08/22	HC Wainwright Adjusts Brickell Biotech's Price Target to $4.50 From $2, Keeps Buy Rating	MT
14/05/22	Lake Street Downgrades Brickell Biotech to Hold From Buy, Lowers Price Target to $0.25 From $2	MT
13/05/22	Oppenheimer Adjusts Brickell Biotech's Price Target to $1 From $4, Maintains Outperform Rating	MT

26/02/25	Fresh Tracks Therapeutics Announces Dissolution, Initial Cash Distribution and Termination of Trading on the OTC Pink Market	PR
29/01/25	Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution	AQ
28/01/25	/C O R R E C T I O N -- Fresh Tracks Therapeutics, Inc./	PR
07/12/24	Fresh Tracks Therapeutics Announces Hearing Date and Notice of Proposed Consent Judgement Regarding Dissolution of Company	PR
18/06/24	Fresh Tracks Therapeutics Announces Delaware Petition Filed Seeking Appointment of Custodian for Eventual Dissolution of Company	AQ

09/03/23	MÄRKTE USA/Uneinheitlich - Zinspfad ungewiss
09/03/23	MÄRKTE USA/Uneinheitlich - Zinssorgen bleiben präsent
09/03/23	MÄRKTE USA/Wall Street mit leichter Erholung
09/03/23	MÄRKTE USA/Wall Street stabilisiert nach Vortagesverlusten
08/03/23	MARKT USA/Wall Street stabilisiert nach Vortagesverlusten

1 day

+2.11%

Manager	Title	Age	Since
Albert Marchio CEO	Chief Executive Officer	74	-
Nancy Seretta CTO	Chief Tech/Sci/R&D Officer	-	01/01/2016
Aaron Fox-Collis DFI	Director of Finance/CFO	-	01/06/2022

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VICAL INCORPORATED	+2.11%	-3.76%	-	-	5.59M
WUXI APPTEC CO., LTD.	-2.59%	-5.70%	+39.83%	+82.45%	70.61B
ARGENX SE	+3.23%	-10.67%	+4.87%	+55.97%	51.01B
LONZA GROUP AG	+1.56%	+1.17%	+5.15%	+33.38%	48.1B
IQVIA HOLDINGS INC.	+0.39%	+0.65%	+28.02%	+30.24%	42.78B
REVOLUTION MEDICINES, INC.	+0.87%	-8.17%	+298.53%	+645.03%	40.67B
BEONE MEDICINES AG	+1.24%	-1.01%	+5.56%	+105.14%	40.3B
CELLTRION, INC.	-2.13%	-1.64%	+7.51%	+50.31%	30.59B
WUXI BIOLOGICS (CAYMAN) INC.	-0.46%	-1.28%	+31.47%	+19.93%	28.16B
BIONTECH SE	+5.32%	+0.06%	-7.20%	-11.30%	24.36B
Average	+0.95%	-2.66%	+45.97%	+112.35%	41.84B
Weighted average by Cap.	+0.56%	-2.94%	+47.30%	+116.51%